Hennion & Walsh Asset Management Inc. Sells 572 Shares of Humana Inc. (NYSE:HUM)

Hennion & Walsh Asset Management Inc. trimmed its stake in Humana Inc. (NYSE:HUM) by 19.3% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,399 shares of the insurance provider’s stock after selling 572 shares during the period. Hennion & Walsh Asset Management Inc.’s holdings in Humana were worth $896,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the stock. Norges Bank acquired a new stake in shares of Humana during the fourth quarter worth $676,800,000. Sanders Capital LLC acquired a new position in shares of Humana in the 4th quarter valued at about $489,300,000. Ontario Teachers Pension Plan Board boosted its position in shares of Humana by 11,647.2% during the 1st quarter. Ontario Teachers Pension Plan Board now owns 1,059,478 shares of the insurance provider’s stock valued at $367,342,000 after purchasing an additional 1,050,459 shares in the last quarter. Putnam Investments LLC grew its stake in Humana by 550.3% during the fourth quarter. Putnam Investments LLC now owns 875,489 shares of the insurance provider’s stock worth $400,808,000 after purchasing an additional 740,858 shares during the period. Finally, Steadfast Capital Management LP bought a new stake in Humana in the first quarter worth approximately $158,813,000. 92.38% of the stock is owned by institutional investors.

Analysts Set New Price Targets

HUM has been the topic of a number of research analyst reports. Deutsche Bank Aktiengesellschaft increased their price target on Humana from $341.00 to $349.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Baird R W upgraded shares of Humana to a “hold” rating in a report on Thursday, May 30th. Morgan Stanley began coverage on shares of Humana in a report on Monday, June 24th. They set an “equal weight” rating and a $374.00 price objective on the stock. TD Cowen raised their target price on Humana from $396.00 to $407.00 and gave the company a “buy” rating in a research note on Wednesday, July 24th. Finally, Oppenheimer boosted their target price on Humana from $370.00 to $400.00 and gave the company an “outperform” rating in a research report on Thursday, August 1st. Thirteen equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, Humana presently has a consensus rating of “Hold” and an average target price of $405.30.

Humana Stock Up 1.1 %

HUM opened at $356.98 on Wednesday. Humana Inc. has a fifty-two week low of $298.61 and a fifty-two week high of $530.54. The firm has a market capitalization of $43.02 billion, a P/E ratio of 22.23, a PEG ratio of 2.09 and a beta of 0.51. The company’s 50-day moving average is $367.78 and its 200 day moving average is $346.46. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.66 and a quick ratio of 1.67.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, topping the consensus estimate of $5.89 by $1.07. The firm had revenue of $29.54 billion for the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a net margin of 1.53% and a return on equity of 16.12%. The company’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter last year, the firm earned $8.94 EPS. Research analysts expect that Humana Inc. will post 16.14 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Monday, September 30th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.99%. The ex-dividend date of this dividend is Monday, September 30th. Humana’s dividend payout ratio (DPR) is currently 22.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.